Detection and Characterization of Proteinase K-sensitive Disease-related Prion Protein with Thermolysin
Overview
Authors
Affiliations
Disease-related PrP(Sc) [pathogenic PrP (prion protein)] is classically distinguished from its normal cellular precursor, PrP(C)(cellular PrP) by its detergent insolubility and partial resistance to proteolysis. Although molecular diagnosis of prion disease has historically relied upon detection of protease-resistant fragments of PrP(Sc) using PK (proteinase K), it is now apparent that a substantial fraction of disease-related PrP is destroyed by this protease. Recently, thermolysin has been identified as a complementary tool to PK, permitting isolation of PrP(Sc) in its full-length form. In the present study, we show that thermolysin can degrade PrP(C) while preserving both PK-sensitive and PK-resistant isoforms of disease-related PrP in both rodent and human prion strains. For mouse RML (Rocky Mountain Laboratory) prions, the majority of PK-sensitive disease-related PrP isoforms do not appear to contribute significantly to infectivity. In vCJD (variant Creutzfeldt-Jakob disease), the human counterpart of BSE (bovine spongiform encephalopathy), up to 90% of total PrP present in the brain resists degradation with thermolysin, whereas only approximately 15% of this material resists digestion by PK. Detection of PK-sensitive isoforms of disease-related PrP using thermolysin should be useful for improving diagnostic sensitivity in human prion diseases.
Kobayashi J, Kanou K, Okura H, Akter T, Fukushi S, Matsuyama S mBio. 2024; 15(11):e0120324.
PMID: 39440974 PMC: 11559096. DOI: 10.1128/mbio.01203-24.
Convergent generation of atypical prions in knockin mouse models of genetic prion disease.
Mehra S, Bourkas M, Kaczmarczyk L, Stuart E, Arshad H, Griffin J J Clin Invest. 2024; 134(15.
PMID: 39087478 PMC: 11291267. DOI: 10.1172/JCI176344.
Mousavi Ghahfarrokhi S, Mahdigholi F, Amin M Arch Microbiol. 2023; 205(12):375.
PMID: 37935975 DOI: 10.1007/s00203-023-03713-7.
Prion assemblies: structural heterogeneity, mechanisms of formation, and role in species barrier.
Igel A, Fornara B, Rezaei H, Beringue V Cell Tissue Res. 2022; 392(1):149-166.
PMID: 36399162 PMC: 10113350. DOI: 10.1007/s00441-022-03700-2.
Stability of BSE infectivity towards heat treatment even after proteolytic removal of prion protein.
Langeveld J, Balkema-Buschmann A, Becher D, Thomzig A, Nonno R, Andreoletti O Vet Res. 2021; 52(1):59.
PMID: 33863379 PMC: 8052740. DOI: 10.1186/s13567-021-00928-8.